RESPeRATE is the only medical device clinically proven to lower blood pressure. Its patented technology enables patients to reduce sympathetic activity, peripheral resistance and lower blood pressure by harnessing the power of paced breathing.
Used for 15 minutes a day, several times a week, RESPeRATE demonstrates significant, all-day blood pressure reduction beyond the reduction from concurrent treatments such as medication, diet and exercise.
RESPeRATE's patented technology enables patients to reduce sympathetic activity, peripheral resistance and lower blood pressure by harnessing the power of paced breathing - at home, without the assistance of a personal coach.
At the beginning of each session, RESPeRATE analyzes the patient's individual breathing rate and pattern, using its respiration sensor and built-in computer. It then creates a personalized melody composed of two distinct guiding tones, one for inhaling, one for exhaling.
The patient listens to the melody and synchronizes breathing to the tones. By gradually prolonging the exhalation tone, RESPeRATE guides the patient to slow his or her breathing, and reach what was demonstrated to be the 'therapeutic zone' of fewer than 10 breaths per minute. Each patient's breathing rate and pattern changes regularly. In response, RESPeRATE's computer automatically detects, monitors and customizes the guiding tones to the patient.
A few minutes after starting the session, the smooth muscles surrounding the small blood vessels relax. Blood flows more freely as the small blood vessels dilate and blood pressure is significantly lowered. The greater lung inflation that accompanies slow breathing activates stretch receptors in the lungs and increases right atrial pre-load that activates cardiac stretch receptors. In response, sympathetic outflow is reduced, leading to a reduction in systemic vascular resistance and blood pressure.
